Wen Zhang

This inventor holds 32 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 9 EPO patents, primarily in Polymeric Conjugates. Top assignees: Nektar Therapeutics, Naktar Therapeutics. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen Zhang. Retrieved from https://idiyas.com/inventor/wen-zhang-c3vmvcyy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 2)

% Patents Active = 84.4

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 3)

Average Co-Inventor Count = 2.6

ph-index = 6

Forward Citations = 95(Granted Patents)

Location History:

Madison, AL (US) (2013 - 2014)
Dublin, CA (US) (2013 - 2015)
San Ramon, CA (US) (2015 - 2023)

Company Filing History:

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

Adenosine Receptor Antagonists

Polymeric Alkanoate Conjugates

Oligomer-Corticosteroid Conjugates

Kappa Opioid Agonists

Dantrolene Conjugates

Protease Inhibitor Conjugates

Protein Tyrosine Kinase Inhibitors

Tricyclic Conjugates

Oligomer-3-Alkoxypropionamides

N-Methyl-N-Phenyl Derivatives

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12325708 - Adenosine 2 receptor antagonists (2025-06-10),

2. 11672776 - Multi-arm polymeric alkanoate conjugates (2023-06-13),

3. 11464788 - Oligomer-corticosteroid conjugates (2022-10-11),

4. 11241415 - N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the κ opioid receptor (2022-02-08),

5. 11111214 - Kappa opioid agonists and uses thereof (2021-09-07),

6. 10407416 - Kappa opioid agonists and uses thereof (2019-09-10),

7. 10322107 - N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor (2019-06-18),

8. 10265411 - N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides (2019-04-23),

9. 10039737 - Multi-arm polymeric alkanoate conjugates (2018-08-07),

10. 9907855 - N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides (2018-03-06),

11. 9815824 - Kappa opioid agonists and uses thereof (2017-11-14),

12. 9725431 - Oligomer-tricyclic conjugates (2017-08-08),

13. 9616136 - N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides (2017-04-11),

14. 9504755 - Multi-arm polymeric alkanoate conjugates (2016-11-29),

15. 9226971 - N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides (2016-01-05),

Title: Innovations by Wen Zhang: A Pioneer in Polymer Conjugates

Introduction

Wen Zhang, based in San Ramon, CA, is a distinguished inventor with an impressive portfolio of 31 patents. His work primarily focuses on the development of innovative polymeric conjugates and their therapeutic applications. His contributions have significantly advanced the field of drug delivery and treatment methodologies.

Latest Patents

Among Wen Zhang's latest patents are the "Multi-arm polymeric alkanoate conjugates," which detail multi-armed polymer conjugates composed of an alkanoate-linker. This invention emphasizes high drug loading efficiencies, and it outlines methods for making and administering these conjugates, which enhance treatment effectiveness. Another noteworthy patent is the "Oligomer-corticosteroid conjugates." This invention involves chemically modifying corticosteroids through covalent attachment of a water-soluble oligomer, resulting in a reduced biological membrane crossing rate compared to unmodified corticosteroids. These innovations represent critical advancements in pharmacology.

Career Highlights

Wen Zhang has held key positions at notable companies such as Nektar Therapeutics and Naktar Therapeutics. His work at these organizations has allowed him to contribute to cutting-edge research and developments in drug delivery systems and therapeutics, reinforcing his reputation as a leader in the industry.

Collaborations

Throughout his career, Wen has collaborated with esteemed colleagues including Jennifer A Riggs-Sauthier and Franco J Duarte. These collaborations have fostered a dynamic exchange of ideas and innovative approaches to science and technology, further amplifying the impact of their combined expertise.

Conclusion

Wen Zhang's contributions to the field of polymer conjugates and drug delivery innovation highlight his significant role as an inventor. With numerous patents to his credit, his work continues to influence research and development, promising advancements in medical treatments. As he progresses in his career, the scientific community eagerly anticipates his future endeavors and the innovations they will bring.

Profile summary based on public USPTO records.